.FDA declines psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Declines to Approve MDMA Treatment, Looking For Additional Study The New York TimesFDA Rejects Ecstasy-Based Medication The Exchange JournalFDA declines to approve novel MDMA therapy to handle post-traumatic stress disorder, along with request for more hearing information CNNFDA denies first experimental to address PTSD, requiring additional research The Washington Post.